Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis.

Benz, Rudolf; Zimmermann, Kathrin; Rechsteiner, Markus; Balabanov, Stefan; Manz, Markus G; Widmer, Corinne C

Benz, Rudolf; Zimmermann, Kathrin; Rechsteiner, Markus; Balabanov, Stefan; Manz, Markus G; Widmer, Corinne C.

Afiliación

Benz R; Division of Hematology and Oncology, Kantonsspital Muensterlingen, Muensterlingen, Switzerland.
Zimmermann K; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Rechsteiner M; Deparment of Pathology, University Hospital of Zurich, Zurich, Switzerland.
Balabanov S; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Manz MG; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Widmer CC; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.

Leuk Lymphoma ; 61(10): 2533-2535, 2020 10.

Article en En | MEDLINE | ID: mdl-32449412

Asunto(s)

Síndromes Mielodisplásicos; Trombocitosis; Humanos; Interferones; Polietilenglicoles; Trombocitosis/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombocitosis / Síndromes Mielodisplásicos Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google